Signal from the log
Magnitude Biosciences
1,3 M£ · Undisclosed · United Kingdom · Biotech
Magnitude Biosciences teste des molécules sur C. elegans, un ver d'un millimètre transparent qui vieillit en trois semaines. Sa plateforme VivoScan filme les vers en continu et mesure leur mouvement, pour voir en quelques semaines ce qu'un organisme entier fait d'un composé. C'est un prestataire d'essais précliniques, spinout de l'université de Durham.
Article
Announced on , logged by the watch of 15 September 2026.
- Operation
- Funding round
- Announced amount
- 1,3 M£
- Stage
- Undisclosed
- Country
- United Kingdom
- Sector
- Biotech
What the log says
Editorial note, in French
Sujet traité. L'article donne les sources et la position de Bolus.
The investors
Led by Northstar Ventures , with Maven Capital Partners
Provenance
Source eu-startups,longevity
Logged on 15 September 2026
Description Written in French during the watch run. Written during the watch run, after reading the issuer's press release or the source article.
Verification Amounts and fund names were double checked against the issuer's press release or an official filing.
What this status means
Article The operation led to an article, with its sources checked one by one.
The rule A signal is never removed from the log. A round set aside stays readable with its reason, because a collection you cannot reread is a collection you cannot correct.